DCZ-0014

N/A

Report date: 2026/01/20 18:01:26
NME

Base Information

Drug NameDCZ-0014
Drug Alias NameDCZ-0014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitorsDNA damage stimulants
TargetsUpdating
Therapy Area/IndicationsLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTongji University
China Registration ClassN/A

Develop Information

Active CompaniesTongji University
Inactive CompaniesN/A
Active IndicationsLymphoma, Large B-Cell, Diffuse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A